Bruno Rodríguez Parrilla, Minister of Foreign Relations of Cuba, today highlighted the government's will to continue working for the well-being and health of the people, despite the limitations caused by the hostile policy of the United States.

The Chancellor underscored, as evidence of this effort, the reactivation of production of 16 cytostatic drugs for the National Program for the Care of Oncology Patients.

Through the social network X, Rodríguez Parrilla noted that this result was made possible following a major investment process at the AICA Laboratories enterprise, which belongs to the Group of Biotechnological and Pharmaceutical Industries (Biocubafarma).

He assured that each drug produced at the plant represents sovereignty, hope, and the commitment to the right to health of all Cubans.

The head of Cuban diplomacy condemned the country's severe economic limitations caused by the extreme intensification of Washington's blockade and an unprecedented energy siege.

When announcing the resumption last week, AICA Laboratories emphasized that this production has a direct impact on the availability of cytostatic drugs within the national basic list, ensuring more timely access for patients requiring these treatments.

According to the entity, the investment process was aimed at strengthening the plant's regulatory standards and equipment.